← FDA DRUG APPROVALS

FDA ANDA · ANDA085014

CHLORDIAZEPOXIDE HYDROCHLORIDE

Sponsor: WEST WARD

APPLICATION
ANDA085014
TYPE
ANDA
ORIGINAL APPROVAL
1977-04-06
LATEST ACTION
1988-05-06
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

CHLORDIAZEPOXIDE HYDROCHLORIDEDiscontinued
CHLORDIAZEPOXIDE HYDROCHLORIDE 5MG · CAPSULE · ORAL

Approval history

1988-05-06Manufacturing (CMC) · Supplement 24AP
1988-05-06Labeling · Supplement 20AP
1984-10-03Manufacturing (CMC) · Supplement 17AP
1984-07-13Manufacturing (CMC) · Supplement 16AP
1983-07-25Manufacturing (CMC) · Supplement 15AP
1982-08-10Manufacturing (CMC) · Supplement 13AP
1977-04-06OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →